Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$25.44 - $59.78 $39,889 - $93,735
-1,568 Reduced 16.65%
7,848 $213,000
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $24,274 - $33,916
556 Added 6.28%
9,416 $507,000
Q2 2022

Aug 09, 2022

SELL
$28.82 - $77.35 $148,480 - $398,507
-5,152 Reduced 36.77%
8,860 $357,000
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $676,079 - $1.41 Million
14,012 New
14,012 $928,000
Q4 2021

Feb 23, 2022

SELL
$88.71 - $120.43 $434,856 - $590,347
-4,902 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$98.77 - $132.17 $484,170 - $647,897
4,902 New
4,902 $613,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.